April 19, 2021
Study Reports Improved Outcomes With Olaparib Maintenance in Ovarian Cancer Maintenance therapy with olaparib was found to result in a clinically meaningful, but not statistically significant, improvement in overall survival compared with placebo among women with platinum-sensitive, BRCA 1/2-mutated, relapsed ovarian cancer, according to the results of a study published in The Lancet Oncology. […]